U.S. Preventive Medicine Acquires Specialty Disease ...(mploying supportiveinformation technolog...),Health

Date:10/2/2007

mploying supportive information technology that drives measurable outcomes. Specialty Disease Management's field-based program has been applied to persons with asthma, diabetes, heart failure, HIV/AIDS, COPD, high risk pregnancy, and for persons with schizophrenia and their associated medical co-morbidities.

Specialty Disease Management was organized in 1997 by health professionals who recognized the value in coordinating care to serve people with chronic diseases. Based in Florida and contracted in six other states, Specialty Disease Management's experience offers numerous assets that are recognized for their unique contribution to disease management programs.

http://www.specialtydisease.com

Contacts:

U.S. Preventive Medicine: Kathy Fleming, USPM, 386-454-8845

or kfleming@uspreventivemedicine.com

U.S. Preventive Medicine: Aprill O. Turner, CooperKatz, 212-455-8016

or aturner@cooperkatz.com

U.S. Preventive Medicine: Nick Sowards, CooperKatz, 212-455-8008

or nsowards@cooperkatz.com

'/>"/>

SOURCE U.S. Preventive Medicine Copyright©2007 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
2. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
3. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
6. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
7. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
8. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
9. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
10. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
11. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD